- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Galectin-1 as a predictive biomarker in ovarian cancer ; volume:14 ; number:1 ; day:23 ; month:9 ; year:2021 ; pages:1-9 ; date:12.2021
Journal of ovarian research ; 14, Heft 1 (23.9.2021), 1-9, 12.2021
- Urheber
-
Masoodi, Mahak
Shah, Zafar A.
Beigh, Afaq H.
Ahmad, Sheikh Zahoor
Mir, Abdul Wahid
Yasin, Besina
Rasool, Roohi
Masoodi, Khalid Z.
Bhat, Gull Mohammad
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-021-00874-1
- URN
-
urn:nbn:de:101:1-2021121422082999702031
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Masoodi, Mahak
- Shah, Zafar A.
- Beigh, Afaq H.
- Ahmad, Sheikh Zahoor
- Mir, Abdul Wahid
- Yasin, Besina
- Rasool, Roohi
- Masoodi, Khalid Z.
- Bhat, Gull Mohammad
- SpringerLink (Online service)
Ähnliche Objekte (12)
Galectin-3 als Biomarker bei Vorhofflimmern
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Platelet protein biomarker panel for ovarian cancer diagnosis
Best serum biomarker combination for ovarian cancer classification
Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients
Predictive factors of endometriosis progression into ovarian cancer
SPON1 is an independent prognostic biomarker for ovarian cancer
MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer
New prognostic and predictive biomarkers in primary ovarian cancer
Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Engrailed-2 (EN2) – a novel biomarker in epithelial ovarian cancer
Galectin-3 als Biomarker bei Vorhofflimmern
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Platelet protein biomarker panel for ovarian cancer diagnosis
Best serum biomarker combination for ovarian cancer classification
Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients
Predictive factors of endometriosis progression into ovarian cancer
SPON1 is an independent prognostic biomarker for ovarian cancer
MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer
New prognostic and predictive biomarkers in primary ovarian cancer
Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Engrailed-2 (EN2) – a novel biomarker in epithelial ovarian cancer
Galectin-3 als Biomarker bei Vorhofflimmern
Morin decreases galectin-3 expression and sensitizes ovarian cancer cells to cisplatin
Platelet protein biomarker panel for ovarian cancer diagnosis
Best serum biomarker combination for ovarian cancer classification
Poster 1002: Galectin-3 as predictive biomarker of airways remodeling modulation in omalizumab treated severe asthma patients
Predictive factors of endometriosis progression into ovarian cancer
SPON1 is an independent prognostic biomarker for ovarian cancer
MicroRNA let-7g acts as tumor suppressor and predictive biomarker for chemoresistance in human epithelial ovarian cancer
New prognostic and predictive biomarkers in primary ovarian cancer
Galectin-3 in prostate cancer and heart diseases: a biomarker for these two frightening pathologies?
MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin